Adamis Pharmaceuticals to Present at Conferences in June 2019
May 29 2019 - 9:00AM
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced
that management is scheduled to present a company overview at two
upcoming conferences in June 2019. During the conferences,
management from Adamis will discuss the company’s business,
regulatory and operational developments.
Details of the conference presentations are as follows:
Event: |
9th Annual LD Micro Invitational Conference |
Date: |
Tuesday, June 4, 2019 |
Time: |
11:00 a.m. Pacific Time (2:00 p.m. Eastern Time) |
Location: |
Luxe Hotel in Los Angeles, California |
|
|
Event: |
Raymond James Life Sciences and MedTech
Conference |
Date: |
Tuesday, June 18, 2019 |
Time: |
10:15 a.m. Pacific Time (1:15 p.m. Eastern Time) |
Location: |
Lotte New York Palace, New York, New York |
About Adamis Pharmaceuticals
Adamis Pharmaceuticals Corporation is a specialty
biopharmaceutical company primarily focused on developing and
commercializing products in various therapeutic areas, including
respiratory disease and allergy. The company’s SYMJEPITM
(epinephrine) Injection 0.3mg and SYMJEPITM (epinephrine) Injection
0.15mg products were approved by the FDA for use in the emergency
treatment of acute allergic reactions, including anaphylaxis.
Adamis previously announced a distribution and commercialization
agreement with Sandoz, a division of Novartis Group, to market
Symjepi in the U.S. Adamis is developing additional products,
including a naloxone injection product candidate for the treatment
of opioid overdose, a sublingual tadalafil product candidate for
the treatment of erectile dysfunction, and a metered dose inhaler
and dry powder inhaler product candidates for the treatment of
asthma and COPD. The company’s subsidiary, U.S. Compounding,
Inc., compounds sterile prescription drugs, and certain nonsterile
drugs for use by hospitals, clinics and surgery centers throughout
most of the United States.
Adamis Contacts
Mark FlatherSenior Director, Investor Relations &Corporate
CommunicationsAdamis Pharmaceuticals Corporation(858)
412-7951mflather@adamispharma.com
Adamis Pharmaceuticals (NASDAQ:ADMP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Adamis Pharmaceuticals (NASDAQ:ADMP)
Historical Stock Chart
From Sep 2023 to Sep 2024